Skip to Main Content

Top of the morning to you. A spot of rain is descending on the Pharmalot campus right now, but our spirits remain sunny, nonetheless. Why? We will trot out a bit of insight from the Morning Mayor, who would say, “Every new day should be unwrapped like a precious gift.” To celebrate the notion, we are brewing still more cups of stimulation and invite you to join us. Our choice today is mountain blueberry. Meanwhile, here are a few items of interest. Hope you have a smashing day, and, of course, do stay in touch. …

Workers at a plant in Baltimore manufacturing two Covid-19 vaccines accidentally conflated the ingredients several weeks ago, contaminating up to 15 million doses of Johnson & Johnson’s (JNJ) vaccine and forcing regulators to delay authorization of the plant’s production lines, The New York Times reports. The plant is run by Emergent BioSolutions (EBS), a manufacturing partner to both J&J and AstraZeneca (AZN), whose vaccine has yet to be authorized for use in the U.S. Federal officials attributed the mistake to human error.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED
  • If memory serves (and it may not …), the BMS issue mentioned above raises echo’s of the so called “Synthes exception” in 2012 that J&J exercised successfully BUT the IRS later said would not be able to be exercised again. The timing of 9 years is instructive?

Comments are closed.